Enfusion Q3 Adj $0.05 Misses $0.06 Estimate, Sales $51.17M Miss $52.17M Estimate

Author: Benzinga Newsdesk | November 04, 2024 07:35am
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is a 25 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $51.17 million which missed the analyst consensus estimate of $52.17 million by 1.92 percent. This is a 15.35 percent increase over sales of $44.36 million the same period last year.

Posted In: ENFN